DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · IEX Real-Time Price · USD
2.390
-0.100 (-4.02%)
Apr 19, 2024, 4:30 PM EDT - Market closed
DiaMedica Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for DMAC stock have an average target of 7.00, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 192.89% from the current stock price of 2.39.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DMAC stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $11 → $8 | Strong Buy | Maintains | $11 → $8 | +234.73% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +151.05% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $7 | Hold → Buy | Upgrades | $7 | +192.89% | Jun 22, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +234.73% | Jul 7, 2022 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $18 → $12 | Strong Buy | Maintains | $18 → $12 | +402.09% | Jul 7, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.74
from -0.60
EPS Next Year
-0.88
from -0.74
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | 56.7M |
| Avg | n/a | n/a | 55.1M |
| Low | n/a | n/a | 52.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.72 | -0.80 | 0.64 |
| Avg | -0.74 | -0.88 | 0.62 |
| Low | -0.76 | -0.94 | 0.60 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.